Haider Mahdi

3.8k total citations
121 papers, 1.7k citations indexed

About

Haider Mahdi is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Haider Mahdi has authored 121 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Reproductive Medicine, 48 papers in Obstetrics and Gynecology and 41 papers in Oncology. Recurrent topics in Haider Mahdi's work include Ovarian cancer diagnosis and treatment (53 papers), Endometrial and Cervical Cancer Treatments (45 papers) and Uterine Myomas and Treatments (19 papers). Haider Mahdi is often cited by papers focused on Ovarian cancer diagnosis and treatment (53 papers), Endometrial and Cervical Cancer Treatments (45 papers) and Uterine Myomas and Treatments (19 papers). Haider Mahdi collaborates with scholars based in United States, United Kingdom and Denmark. Haider Mahdi's co-authors include David Lockhart, Mehdi Kebria, Adnan Munkarah, Peter G. Rose, Rouba Ali‐Fehmi, Chad M. Michener, Sanjeev Kumar, Amelia Jernigan, Robert Morris and Peter S. Rose and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Haider Mahdi

111 papers receiving 1.6k citations

Peers

Countries citing papers authored by Haider Mahdi

Since Specialization

Citations

This map shows the geographic impact of Haider Mahdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haider Mahdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haider Mahdi more than expected).

Fields of papers citing papers by Haider Mahdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haider Mahdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haider Mahdi. The network helps show where Haider Mahdi may publish in the future.

Co-authorship network of co-authors of Haider Mahdi

This figure shows the co-authorship network connecting the top 25 collaborators of Haider Mahdi. A scholar is included among the top collaborators of Haider Mahdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haider Mahdi. Haider Mahdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adjuvant therapy in early uterine serous carcinoma 2025 ·American Journal of Epidemiology ·(unknown), (unknown), T. Rinda Soong, (unknown), Sarah E. Taylor, Lan Coffman, Ronald J. Buckanovich, Haider Mahdi, Sushil Beriwal, Paniti Sukumvanich, Rohit Bhargava, Alexander Olawaiye	1
2	Metabolic signatures of immune checkpoint inhibitor response in gynecologic cancers: Insights from flux balance analysis 2025 ·Computers in Biology and Medicine ·(unknown), Lin Li, Lamis Yehia, Haider Mahdi, Ying Ni	0
3	A phase I/II study of maplirpacept in combination with pegylated liposomal doxorubicin (PLD) in patients with platinum-resistant ovarian cancer (OC): Phase 1 results. 2024 ·Journal of Clinical Oncology ·Daron Street, (unknown), David Starks, Haider Mahdi, Carlos Linn, Dmitri Pavlov, (unknown), Sant P. Chawla, Ingmar Bruns, Steven Waggoner	2
4	Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer 2023 ·Journal for ImmunoTherapy of Cancer ·Mary L. Disis, Sarah F. Adams, Jyoti Bajpai, Marcus O. Butler, Tyler J. Curiel, (unknown), Laura Doherty, Leisha A. Emens, Claire F. Friedman, Margaret E. Gatti‐Mays, Melissa A. Geller, Amir A. Jazaeri, Veena S. John, Katherine C. Kurnit, John B. Liao, Haider Mahdi, Anne M. Mills, Emese Zsíros, Kunle Odunsi	14
5	Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer 2022 ·JCI Insight ·Lan Coffman, (unknown), (unknown), Leonard Frisbie, Daniel P. Normolle, Kent A. Griffith, Shitanshu Uppal, Karen McLean, Jessica Berger, M.M. Boisen, Madeleine Courtney‐Brooks, Robert P. Edwards, Jamie Lesnock, Haider Mahdi, Alexander Olawaiye, Paniti Sukumvanich, Sarah E. Taylor, Ronald J. Buckanovich	13
6	Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition 2021 ·Science Advances ·Sandra Cascio, Chelsea Chandler, (unknown), (unknown), Bingsi Gao, Sayali Onkar, Tullia C. Bruno, Dario A.A. Vignali, Haider Mahdi, Hatice U. Osmanbeyoglu, Anda Vlad, Lan Coffman, Ronald J. Buckanovich	54
7	Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations) 2021 ·JCO Precision Oncology ·Haider Mahdi, Navid Hafez, Deborah B. Doroshow, Davendra Sohal, (unknown), T. Khanh, Patricia LoRusso, Juliane M. Jürgensmeier, (unknown), Jeffrey Sklar, Colin P. Glover, Brunella Felicetti, Emma Dean, Peter G. Mortimer, Geoffrey I. Shapiro, Joseph P. Eder	56
8	Trends in Survival of Patients With Uterine Serous Carcinoma From 1988 to 2011 2017 ·International Journal of Gynecological Cancer ·Haider Mahdi, Xiaozhen Han, Laura Chambers, Roberto Vargas	6
9	The Impact of Combined Radiation and Chemotherapy on Outcome in Uterine Clear Cell Carcinoma Compared with Chemotherapy Alone 2016 ·Clinical Oncology ·Haider Mahdi, (unknown), Benjamin Nutter, Sheen Cherian, Peter G. Rose	2
10	Prostate-Type Adenocarcinoma in Mature Cystic Ovarian Teratoma 2015 ·International Journal of Gynecological Pathology ·(unknown), Haider Mahdi, (unknown), Holly Harper, Dale R. Shepard, Peter S. Rose, Andres A. Roma	5
11	Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study 2015 ·Gynecologic Oncology ·Haider Mahdi, Peter G. Rose, (unknown), Adnan Munkarah, Derek Isrow, (unknown), Steven Waggoner, Rouba Ali‐Fehmi, (unknown), (unknown), (unknown)	17
12	The Impact of Percent Reduction in CA-125 Levels on Prediction of the Extent of Interval Cytoreduction and Outcome in Patients With Advanced-Stage Cancer of Müllerian Origin Treated With Neoadjuvant Chemotherapy 2015 ·International Journal of Gynecological Cancer ·Haider Mahdi, Kathryn A. Maurer, Benjamin Nutter, Peter G. Rose	20
13	Significance of Lymphovascular Space Invasion in Uterine Serous Carcinoma 2014 ·International Journal of Gynecological Pathology ·Ira Winer, (unknown), İsmail Mert, Subhayu Bandyopadhyay, Michele L. Coté, Adnan Munkarah, Yaser Hussein, Zaid Al-Wahab, Mohamed A. Elshaikh, (unknown), Daniel Schultz, Haider Mahdi, Marisa R. Nucci, Koen Van de Vijver, Robert Morris, Esther Oliva, Rouba Ali‐Fehmi	28
14	Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study 2014 ·Gynecologic Oncology ·Mohamed A. Elshaikh, Zaid Al-Wahab, Haider Mahdi, Kevin Albuquerque, Meredith Mahan, Siobhan M. Kehoe, Rouba Ali‐Fehmi, Peter G. Rose, Adnan Munkarah	22
15	Racial Disparity in 30-Day Morbidity and Mortality After Surgery for Ovarian Cancer 2014 ·International Journal of Gynecological Cancer ·Haider Mahdi, Amelia Jernigan, David Lockhart, Mehdi Kebria, Peter G. Rose	11
16	Clinical and Pathologic Characteristics of Serous Carcinoma Confined to the Endometrium 2013 ·International Journal of Gynecological Pathology ·Assaad Semaan, İsmail Mert, Adnan Munkarah, Subhayu Bandyopadhyay, Haider Mahdi, Ira Winer, Marisa R. Nucci, Yaser Hussein, (unknown), (unknown), (unknown), (unknown), Daniel Schultz, Michele L. Coté, Koen Van de Vijver, Robert Morris, Esther Oliva, Rouba Ali‐Fehmi	21
17	Peripartum Robotic-Assisted Laparoscopic Hysterectomy After Second-Trimester Pregnancy Loss With Placenta Increta 2013 ·Obstetrics and Gynecology ·(unknown), Haider Mahdi, (unknown), Mehdi Kebria	6
18	Endometrial cancer in Asian and American Indian/Alaskan Native women: Tumor characteristics, treatment and outcome compared to non-Hispanic white women 2013 ·Gynecologic Oncology ·Haider Mahdi, Cary Jo R. Schlick, (unknown), Mehdi Kebria, Chad M. Michener	31
19	Feasibility and Optimal Dosage of Indocyanine Green Fluorescence for Sentinel Lymph Node Detection Using Robotic Single-Site Instrumentation: Preclinical Study 2013 ·Journal of Minimally Invasive Gynecology ·Kimberly Levinson, Haider Mahdi, Pedro F. Escobar	14
20	Prognostic Impact of Laterality in Malignant Ovarian Germ Cell Tumors 2011 ·International Journal of Gynecological Cancer ·Haider Mahdi, Sanjeev Kumar, Shelly Seward, Assaad Semaan, Ramesh B. Batchu, David Lockhart, Hisham K. Tamimi, Adnan Munkarah	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact